Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 727 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
百济神州有限公司自愿披露关于美国食品药品监督管理局批准百悦达用于复发难治性套细胞淋巴瘤治疗的公告
Regulatory Filings Classification · 85% confidence The document is a voluntary disclosure announcement by BeiGene regarding FDA accelerated approval of their drug Beqelzi for relapsed/refractory mantle cell lymphoma. It contains no financial statements, no voting outcomes, no management or board changes, nor any form 10-K, earnings release, or financing update. It is a routine regulatory announcement of a material event under stock‐exchange disclosure rules, making it a general Regulatory Filing (RNS).
2026-05-13 Chinese
港股公告：授出受限制股份单位
Share Issue/Capital Change Classification · 85% confidence The document is a Hong Kong Stock Exchange announcement under Listing Rules 17.06A/B/C regarding the grant of restricted share units (RSUs) under the company’s 2016 Option and Incentive Plan. It details the issue of new American Depositary Shares (equivalent to ordinary shares), vesting schedule, and total shares to be issued. This is an announcement of a capital change (issuance of shares) rather than financial statements, management discussion, or other categories. Therefore, it falls under Share Issue/Capital Change (Code: SHA).
2026-05-13 Chinese
美股公告：表格S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 registration statement filed with the U.S. Securities and Exchange Commission (SEC) by BeOne Medicines Ltd. It is a detailed registration statement under the Securities Act of 1933, used for registering securities for public offering. The text includes a prospectus describing the securities to be offered, details about the company, risk factors, selling shareholders, and other disclosures typical of a registration statement. It is not an annual report, earnings release, or any other report type but a capital markets filing related to securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed substantive information about the securities offering, not just an announcement or certification. Hence, the classification is CAP with high confidence.
2026-05-07 Chinese
美股公告：表格S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 registration statement filed with the U.S. Securities and Exchange Commission (SEC) by BeOne Medicines Ltd. It is a detailed prospectus (招股说明书) describing the securities to be offered, including common stock, preferred stock, debt securities, warrants, and units. The document includes extensive information about the company, risk factors, capital structure, use of proceeds, shareholder information, and legal matters. It is clearly a registration statement and prospectus for securities issuance under the Securities Act of 1933, not a financial report, earnings release, or management discussion. The document is lengthy (15,000 characters) and contains the full prospectus text, not just an announcement or a brief summary. Therefore, the appropriate classification is Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including registration statements and prospectuses for securities offerings.
2026-05-07 Chinese
港股公告：证券变动月报表
Regulatory Filings Classification · 95% confidence The document is a monthly securities movement report submitted to the Hong Kong Stock Exchange (HKEX) under Chapter 19B of the Listing Rules. It details changes in registered capital, issued shares, share options, and confirms compliance with public float requirements. It includes specific data on share capital, share options, and confirmations by the company's executive director and CEO. The document is titled as a monthly report and does not contain financial statements or management discussion. It is a regulatory compliance filing related to share capital and securities movements rather than a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS). The document length (5724 characters) and detailed content confirm it is not a brief announcement but a formal regulatory report.
2026-05-07 Chinese
百济神州有限公司自愿披露关于2026年度经营业绩预测调整的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement regarding the adjustment of the company's 2026 annual operating performance forecast. It provides updated financial projections and explanations for the adjustments, including revenue, costs, and risks. The document is relatively short (2016 characters) and does not contain actual audited financial statements or comprehensive financial data. It is an announcement about the forecast adjustment rather than a full financial report or earnings release. Therefore, it fits best into the category of a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-06 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.